Sale!

KIF1B Gene CMT2A1 Genetic Test

4,400 د.إ

-21%

The KIF1B gene plays a crucial role in the development and function of peripheral nerves. Mutations in the KIF1B gene are associated with Charcot-Marie-Tooth disease type 2A1 (CMT2A1), a genetic disorder characterized by the degeneration of peripheral nerves, leading to muscle weakness and sensory loss primarily in the arms and legs. The CMT2A1 genetic test is a specialized diagnostic tool designed to detect mutations in the KIF1B gene, confirming the diagnosis of CMT2A1 and facilitating appropriate clinical management and genetic counseling.

Performed at DNA Labs UAE, the CMT2A1 genetic test is conducted using advanced genetic sequencing technologies to provide accurate and reliable results. The test is priced at 4400 AED and is aimed at individuals who have clinical symptoms of CMT2A1 or have a family history of the disease. Early and precise diagnosis through the CMT2A1 genetic test can be crucial for the management of symptoms, understanding the risk of transmission to offspring, and exploring potential treatment options.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

KIF1B Gene CMT2A1 Genetic Test

Cost: AED 4400.0

Test Name: KIF1B Gene CMT2A1 Genetic Test

Components: NGS Technology

Price: AED 4400.0

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for KIF1B Gene CMT2A1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with KIF1B Gene CMT2A1.

Test Details

The KIF1B gene is associated with Charcot-Marie-Tooth disease type 2A1 (CMT2A1), a genetic disorder that affects the peripheral nerves. This condition leads to muscle weakness and wasting, sensory loss, and difficulty with coordination and balance.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of an individual’s genes. This type of testing can identify variations or mutations in the KIF1B gene that may be associated with CMT2A1. NGS testing is a highly accurate and efficient method for genetic analysis, allowing for the detection of multiple genetic mutations in a single test.

This testing can help diagnose CMT2A1 early on, enabling individuals to receive appropriate treatment and management of their symptoms.

Test Name KIF1B Gene CMT2A1 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for KIF1B Gene CMT2A1 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with KIF1B Gene CMT2A1
Test Details

KIF1B gene is associated with Charcot-Marie-Tooth disease type 2A1 (CMT2A1), which is a genetic disorder that affects the peripheral nerves. This condition leads to muscle weakness and wasting, sensory loss, and difficulty with coordination and balance.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of an individual’s genes. This type of testing can identify variations or mutations in the KIF1B gene that may be associated with CMT2A1.

NGS testing is a highly accurate and efficient method for genetic analysis, allowing for the detection of multiple genetic mutations in a single test. This testing can help diagnose CMT2A1 early on, enabling individuals to receive appropriate treatment and management of their symptoms.